Emami's Q4FY26 results show revenue dipped 4% to ₹925 Cr, with PAT at ₹143 Cr.

Full-year FY26 revenue was ₹3780 Cr, with PAT at ₹775 Cr.

Crucially, the domestic non-summer business grew a healthy 11% in Q4, showing core strength despite a weak summer portfolio and a 5% drop in international sales due to West Asia issues.

Organised channels now make up 32% of domestic business.

Emami is strategically expanding into new-age FMCG.

They've increased their stake in Axiom Ayurveda (AloFrut beverages) and are acquiring a majority stake in IncNut (Vedix, SkinKraft personalized beauty), boosting their digital-first brand portfolio.

Cost controls led to a 250-basis point gross margin improvement in Q4. Management believes Q4's challenges were temporary, expecting improved momentum from Q1FY27. The company remains debt-free with ₹883 Cr net cash, poised for long-term growth and strategic investments.